×

Protea Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

Protea Biosciences, Inc. Logo

NEW YORK, Sept. 9, 2013 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. ("Protea"), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.

Stephen Turner, Chief Executive Officer of Protea Biosciences, will provide an overview of the Company's business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

If you are an institutional investor, and would like to attend the Company's presentation, please click on the following link (www.rodm.com) to register for the Rodman & Renshaw conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.

Follow the official Rodman & Renshaw handle on Twitter @Rodman_2013 and use #Rodman2013 for conference information and updates.

Event: 15th Annual Rodman & Renshaw Global Investment Conference
Date: September 10, 2013
Time: 9:10 AM (Eastern Time)
Location: Room 7.02, 7th Floor; Millennium Broadway Hotel in New York City

About Protea Biosciences Group, Inc.

Protea is a technology leader in the field of mass spectrometry ("mass spec") molecular imaging - the identification and localization of the molecular products of living cells, that is foundational science for all pharmaceutical, medical, and life science research.

Forward-Looking Statements

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements, as described in our reports filed with the Securities and Exchange Commission which are available for review at www.sec.gov, to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

About Rodman & Renshaw Conferences, LLC

The Rodman & Renshaw Annual Global Investment Conference is an informational service and networking opportunity for companies and investors. Rodman does not prepare, review or edit the presentations and other information provided by each company, and does not take any responsibility for the accuracy or adequacy of any such information as the basis for any investment decision. Rodman is not providing any person with any investment advice through their participation in or attendance of the Conference, nor is Rodman soliciting any offers to buy or sell any security of any company.

Protea and LAESI are registered trademarks of Protea Biosciences Group, Inc.

CONTACT: Protea Biosciences Group, Inc. 955 Hartman Run Road, Morgantown, WV 26507 USA Phone: 304.292.2226 Fax: 304.292.7101 Steve.oloughlin@proteabio.com www.proteabio.com

Source:Protea Biosciences, Inc.